Pharmakon Pharmaceuticals, Inc.
FDA Regulatory Profile
Pharmakon Pharmaceuticals, Inc. has 116 FDA recalls (5 Class I), 3 inspections, 0 510(k) clearances and 1 compliance action on record.
- Latest recall
- D-1312-2016 · Class II · Apr 20, 2016
- Latest inspection
- Mar 16, 2016 · OAI
Reviewing Pharmakon Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Check this supplier
Or check Pharmakon Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Get a free API key
Summary
Record counts and when each FDA source was last refreshed
| Records | Count | Last refreshed | Source as of | Status |
| Recalls | 116 (5 Class I) | Nov 8, 2026 | File dated Nov 3, 2026 | Current |
| 510(k) clearances | 0 | Nov 8, 2026 | File dated Nov 2, 2026 | Current |
| Inspections | 3 | Nov 11, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 1 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
Recent Recalls
| Number | Class | Product | Date |
| D-1312-2016 | Class II | Hydromorphone HCI 1 mg/mL in 0.9% Sodium Chloride, 50 mL lntravia bag IV USE ONLY, Rx Only… | Apr 20, 2016 |
| D-1313-2016 | Class II | Atropine Sulfate 0.4mg/mL 2.5 mL fill in a 3 mL syringe, Rx Only, Compounded by PHARMAKON… | Apr 20, 2016 |
| D-1338-2016 | Class II | Midazolam HCI 1mg/mL in 0.9% Sodium Chloride ,2 mL fill in a 3 mL syringe; Compounded by PHARMAKON… | Apr 20, 2016 |
| D-1341-2016 | Class II | Midazolam HCl 1mg/mL in 0.9% Sodium Chloride, 50 mL Intravia bag, Rx Only, Compounded by PHARMAKON… | Apr 20, 2016 |
| D-1343-2016 | Class II | Bupivacaine HCI 0.25% in 0.9% Sodium Chloride, 500 mL Intravia bag, Rx Only, Compounded by… | Apr 20, 2016 |
| D-1258-2016 | Class II | Fentanyl Citrate 2 mcg/mL/Ropivacaine HCI 0.2% injection in 0.9% Sodium Chloride, 100 mL bag, Rx… | Apr 20, 2016 |
| D-1325-2016 | Class II | HYDROmorphone HCI 1mg/mL in 0.9% Sodium Chloride 30 mL fill in a 35 mL Monoject Plungerless Syringe… | Apr 20, 2016 |
| D-1266-2016 | Class II | Epinephrine (PF) 10mcg/mL in 0.9% Sodium Chloride, 5ml syringe, Rx Only, Compounded by PHARMAKON… | Apr 20, 2016 |
| D-1326-2016 | Class II | HYDROmorphone HCI 0.2 mg/mL in 0.9% Sodium Chloride 50 mL fill in a 60 mL Monoject Syringe, Rx Only… | Apr 20, 2016 |
| D-1275-2016 | Class II | Promethazine 12.5mg added to 0.9% Sodium Chloride 50 mL fill in a 100 mL B/Braun PAB bag, Rx Only… | Apr 20, 2016 |
| D-1256-2016 | Class II | Phenylephrine 40 mcg/mL injection in 0.9% Sodium Chloride 10 mL syringe, Rx Only, Compounded by… | Apr 20, 2016 |
| D-1286-2016 | Class II | Fentanyl Citrate 25 mcg/mL in 0.9% Sodium Chloride 25 mL in 30 mL syringe, Rx Only, Compounded by… | Apr 20, 2016 |
| D-1298-2016 | Class II | Oxytocin 30 Units added to Lactated Ringers in a 500 mL lntravia bag, Rx Only, Compounded by… | Apr 20, 2016 |
| D-1281-2016 | Class II | Morphine Sulfate (PF) 0.5mg/mL in 0.9% Sodium Chloride 1mL fill in a 3 mL syringe, Rx Only… | Apr 20, 2016 |
| D-1329-2016 | Class II | Ketamine 2 mg/mL in 0.9% Sodium Chloride 30 mL fill in a 35 mL Monoject Plungerless syringe, Rx… | Apr 20, 2016 |
| D-1287-2016 | Class II | Ketamine 50mg/mL in 0.9% Sodium Chloride 1mL fill in 3 mL syringe, Rx Only, Compounded by PHARMAKON… | Apr 20, 2016 |
| D-1304-2016 | Class II | HYDROmorphone HCI 0.4mg/ml in 0.9% Sodium Chloride, 30 mL PCA Vial, Rx Only, Compounded by PHARMAKON… | Apr 20, 2016 |
| D-1320-2016 | Class II | Fentanyl Citrate 2mcg/mL & Ropivacaine HCI 0.2% in 0.9% Sodium Chloride, 100 mL bag, Compounded by… | Apr 20, 2016 |
| D-1283-2016 | Class II | Morphine Sulfate 1mg/mL in 0.9% Sodium Chloride 50 mL fill in a 50 mL Cadd Cassette (grey), Rx Only… | Apr 20, 2016 |
| D-1310-2016 | Class II | Fentanyl Citrate 5 mcg/mL & Bupivacaine 0.06% in 0.9% Sodium Chloride, 60 mL BD Syringe, Rx Only… | Apr 20, 2016 |
Recent FDA Inspections
NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.
FDA-Inspected Facilities
| Facility | Location | Inspections | Latest |
| FEI 3008213711 | Noblesville, IN | 3 | Mar 16, 2016 |